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Purpose: Biologically uncommon D-β-aspartyl (D-β-Asp) residues have been detected in proteins from various human
tissues from elderly donors and are connected with cataract, age-related macular degeneration, Alzheimer disease and
UV-irradiated skin. In a previous study, we prepared a highly specific antibody against the peptide Gly-Leu-D-β-Asp-
Ala-Thr-Gly-Leu-D-β-Asp-Ala-Thr-Gly-Leu-D-β-Asp-Ala-Thr (designated peptide 3R) that corresponds to three repeats
of positions 149–153 of human lens αA-crystallin. This antibody clearly distinguishes between the different configurations
of the Asp residue in that it reacted strongly with the D-β-Asp-containing peptides but did not react with L-α-Asp-, L-β-
Asp-, or D-α-Asp-containing peptides. However, it remains unclear whether the antibody recognizes the amino acid
sequences surrounding the D-β-Asp residue. The purpose of the present study is to elucidate the sequence dependency of
the epitope of the antigen.
Methods: To clarify the properties of the anti-peptide 3R antibody, we used F-moc (9-fluorenylmethoxycarbonyl) solid
phase chemistry to synthesize various peptides and analogs based on the peptides T18 (I146QTGLDATHAER157) and T6
(T55VLDAGISEVR65) which correspond to amino acid sequences 146–157 and 55–65, respectively of human αA-
crystallin. The specificity of antibody was confirmed by ELISA (enzyme-linked immunosorbent assay) using these
peptides.
Results:  The  anti  peptide  3R  antibody  specifically  recognized  D-β-Asp  residues  and  does  not  react  with  other
configurations of Asp such as the L-α, L-β, D-α isomers in peptides. When the Ala in the peptide was replaced by other
amino acid residues, the antibody did not react with the antigen. The antibody requires the sequence Leu-D-β-Asp-Ala to
detect D-β-Asp containing proteins in living tissue.
Conclusions: The anti peptide 3R antibody is a powerful and easy tool for detection of D-β-Asp containing proteins in
living tissues from patients with age-related diseases. However, to detect the D-β-Asp containing proteins in the living
tissues using the anti-peptide 3R antibody, the protein must contain the sequence Leu-D-β-Asp-Ala.
Proteins consist exclusively of L-amino acids in living
tissues.  However,  D-aspartyl  (Asp)  residues  have  been
detected in various proteins of tooth [1], eye lens [2-5], aorta
[6], brain [7,8], bone [9], and skin [10,11] in elderly donors.
Importantly,  the  proteins  containing  D-amino  acids  are
derived from tissues that are metabolically inert. Thus, D-
amino acid residues arise due to racemization of amino acids
in the protein during the life span of the individual. Of all the
naturally occurring amino acids, aspartic acid (Asp) is the
most susceptible to racemization. However, the specific sites
in which racemization of Asp residues in proteins occurs has
not been determined except for lens and brain proteins in the
reports described above.
In our previous study, we found that specific Asp residues
in αA-crystallin (Asp 58 and Asp 151) [3], αB-crystallin (Asp
36 and Asp 62) [4], and βB2-crsytallin (Asp 4) [5] in the
human lens were highly inverted from the L-isomer to the D-
isomer and the peptide bond isomerized from the normal α-
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linkage to a β-linkage. In proteins these isomers can cause
major  changes  in  structure,  since  different  side  chain
orientations  can  induce  an  abnormal  peptide  backbone.
Therefore, the presence of the isomers may be one of triggers
of abnormal aggregation and can induce the partial unfolding
of protein leading to a disease state. In fact, the previous study
clearly showed that α-crystallin containing large amounts of
D-β-Asp undergoes abnormal aggregation to form massive
and heterogeneous aggregates, leading to loss of its chaperone
activity [12]. Similarly, we observed the accumulation of D-
β-Asp containing proteins in sun-damaged face skin from
elderly people [11]. The abnormal protein was localized to the
elastic fiber-like structures of dermis from elderly donors with
actinic elastosis [13].
These findings indicate that D-β-Asp residues are present
widely and arise due to racemization of amino acids in various
proteins during the lifespan of the individual. Therefore, it is
necessary to be able to detect D-β-Asp containing proteins in
the living tissues of elderly donors. We have detected specific
sites of D-β-Asp in proteins from cataractous lenses using the
following steps: 1) Purification of the target protein using
various column chromatographic methods, 2) Digestion of the
protein obtained in step 1 with trypsin, 3) Separation of the
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996tryptic peptides obtained in step 2 by reversed phase high
performance  liquid  chromatography  (RP-HPLC),  4)
Identification of the tryptic peptides by sequence analysis and
mass spectrometry, 5) Analysis of β/α ratio of Asp in peptide ;
since the β-Asp containing peptides are clearly separated from
normal α-Asp containing peptides upon RP-HPLC, the β/α
ratios of the Asp residues in the peptides are calculated from
the ratio of the peak areas. The confirmation of a β-Asp residue
in peptides is performed by protein sequencing because the
β-Asp containing peptides are resistant to Edman degradation.
6) Analysis of D/L ratio of Asp in peptide; to determine the
D/L ratio of the Asp residue in a peptide, the identified tryptic
peptides  are  hydrolyzed  and  derivatized  to  form
diastereoisomers using o-phthalaldehyde (OPA) and N-tert-
butyloxycarbonyl-L-cysteine  (Boc-L-cys).  The
diastereoisomers are then subjected to RP-HPLC and the D/L
ratio of amino acids determined by analyzing the ratio of the
respective peak areas. According to the above methods, we
determined that the D/L ratios of Asp 58 in the T6 peptide
(TVLD58SGISEVR),  Asp  151  in  the  T18  peptide
(IQTGLD151ATHAER) of αA-crystallin and Asp 4 in the T1
peptide (MASD4HQTQAGK) of βB2-crystallin from elderly
donors were 3.2, 5.8 and 3.2, respectively. This method is
precise and quantitative for the analysis of the contents of
specific  D-β-Asp  sites  in  protein.  However,  it  is  time
consuming to detect D-β-Asp in any protein because of the
complicated  methodology  which  includes  several  column
steps. For this reason, we prepared a highly specific antibody
against the peptide Gly-Leu-D-β-Asp-Ala-Thr-Gly-Leu-D-β-
Asp-Ala-Thr-Gly-Leu-D-β-Asp-Ala-Thr (designated peptide
3R) that corresponds to three repeats of positions 149–153 of
human lens αA-crystallin. This antibody clearly distinguishes
the configuration of the Asp residue, in that it reacts strongly
with D-β-Asp-containing peptides but does not react with L-
α-Asp-,  L-β-Asp-,  or  D-α-Asp-containing  peptides  [14].
Immunohistochemical  staining  of  human  lens  with  this
antibody  demonstrated  that  D-β-Asp-151-containing  αA-
crystallin was predominantly localized to the core of aged
human lens while in the young lens, immunostaining was not
observed [14]. The result was consistent with that of our
previous  biochemical  study  [3].  Therefore,  peptide  3R
immunoreactive protein is considered to be equivalent to D-
β-Asp-containing peptide/protein. Using this antibody, D-β-
Asp-containing  peptide/proteins  were  observed  in
nonpigmented ciliary epithelial cells, in drusen, and in the
sclera [15] of eye and in the sun-damaged skin of elderly
donors [11] and epithelial skin of mouse [16]. Moreover, the
previous  study  reported  that  D-β-Asp-containing  peptide/
protein and advanced glycation end products (AGEs), which
are induced by a nonenzymatic glycation under oxidative
stress, commonly accumulated in the same proteins during
aging [16]. This result means that the isomerization of Asp
and AGE are the results of oxidative stress. Therefore, rapid
and easy analysis of the D-β-Asp-containing peptide/proteins
is required. The purpose of the present study was to investigate
the general applicability of the antibody and the sequence
dependency of the epitope of the antigen.
METHODS
The synthesis of the peptides containing four different Asp
isomers: We synthesized T18 peptides (IQTGLDATHAER)
and T6 peptides (TVLDSGISEVR) of αA-crystallin and T1
peptide of βB2-crystallin (MASDHQTQAGK) together with
related peptides in which amino acids surrounding the Asp
residues were substituted. In addition to the above peptides,
we synthesized a peptide (NRKDAEEWFNQK) from keratin
10 of mouse skin. Furthermore, isomeric peptides containing
4 different Asp isomers, L-α-Asp-, L-β-Asp-, D-α-Asp or D-
β-Asp were also synthesized. The peptides synthesized in this
study are shown in Table 1.
The peptides containing four different Asp isomers were
synthesized  by  Fmoc  (9-ﬂuorenylmethoxycarbonyl)  solid-
phase  chemistry  using  an  automated  solid-phase  peptide
synthesizer (PSSM-8; Shimadzu, Kyoto, Japan). Fmoc-L-Asp
(OtBu)-OH,  Fmoc-D-Asp  (OtBu)-OH,  Fmoc-L-Asp-OtBu
and  Fmoc-D-Asp-OtBu  were  used  as  building  blocks  to
synthesize L-α-, D-α-, L-β- and D-β-isomers, respectively.
The coupling reaction was performed using each Fmoc amino
acid (10 equiv), PyBOP (10 equiv), 1-hydroxybenzotriazole
(HOBt)  (10  equiv),  N-methylmorpholine  (7.5  equiv)  in
dimethylformamide (DMF). The N-terminal Fmoc group was
de-blocked  with  20%  piperidine  in  DMF.  Simultaneous
cleavage of the peptide from the resin and removal of the
protective groups was achieved by treatment with a cocktail
containing  90%  TFA,  5%  1,2-ethanedithiol  and  5%
thioanisole.
Purification of the synthetic peptides: The crude peptides
were purified by RP-HPLC using a C18 column (Capcell pak
C18 ACR, 30 × 250 mm; Shiseido, Tokyo, Japan) with a linear
gradient of 0%–50% acetonitrile in the presence of 0.1% TFA,
at a flow rate of 3.0 ml/min, with monitoring at 215 nm. The
purity of each peptide was confirmed to be >95% by analytical
RP-HPLC.
Characterization  of  the  synthetic  peptides  by  MALDI-
TOFMS: The purity of the synthetic peptides was confirmed
by mass spectrometry. The desalted peptide solution (5 μl)
was mixed with an equal volume (5 μl) of matrix solution. As
matrix solution, α-cyano-4-hydroxycinnamic acid (CHCA,
10 mg) was dissolved in 1 ml of a solution containing a 1:1
ratio of aqueous 0.1% trifluroacetic acid and acetonitrile. The
mixture of peptide and matrix was spotted onto a 384-spot
MALDI target and then dried. All spectra were obtained using
a  matrix-assisted  laser  desorption/ionization  time-of-flight
(MALDI-TOF)  mass  spectrometer  (AXIMA  TOF2;
Schimadzu, Kyoto, Japan). The MALDI-TOF equipment was
operated with a nitrogen laser with a wavelength of 337 nm
and ion acceleration voltage of 20 kV. The data were collected
in reflection mode as signals of positive ions.
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997Antibody  against  D-β-Asp  containing  peptide:  The
preparation  and  characterization  of  the  antibody  used  are
described in our previous paper [14]. Briefly, the polyclonal
antibody against the peptide Gly-Leu-D-β-Asp-Ala-Thr-Gly-
Leu-D-β-Asp-Ala-Thr-Gly-Leu-D-β-Asp-Ala-Thr
(designated peptide 3R), containing three repeats of position
149–153 of human αA-crystallin optic isomer, was purified
from rabbit serum by affinity chromatography using peptide
3R and bovine αA-crystallin as ligands. The anti peptide 3R
antibody clearly distinguished the configuration of the Asp-
residue,  such  that  it  reacted  very  strongly  with  D-β-Asp
containing peptide but did not react with L-α-Asp, D-α-Asp
and L-β-Asp-containing peptides [14]. The antibody clearly
recognized the presence of D-β-Asp containing αA-crystallin
in aged human lenses [14].
Enzyme-linked immunosorbent assay (ELISA): To confirm
the reactiveness of the antibody, ELISAs were performed
using ELISA Plates from IWAKI (Tokyo, Japan). Initially,
target peptide was adjusted with PBS to 1 μg/ml, and 50 μl/
well added to the ELISA plate. The plate was incubated over
night at 4 °C. After incubating, wells were washed once with
washing solution (0.1% PBS-Tween). After washing, 200 μl/
well blocking solution (5% BSA-PBS) was added. The plate
was then incubated for one hour at 25 °C. After incubating
wells  were  washed  3  times  with  washing  solution.  After
washing, 50 μl/well of antibody diluted 10 times and 100 times
with PBS was added. The plate was incubated for one hour at
25 °C. After incubation, the wells were washed 5 times with
wash  solution.  After  washing,  50  μl/well  of  secondary
antibody ((HRP)-conjugated anti rabbit IgG antibody) diluted
1:10,000 with PBS was added. The plate was incubated for
one hour at 25 °C. After incubation wells were washed 5 times
with wash solution. After washing 100 μl/well, stain solution
(stabilized chromogen; Invitrogen, Carlsbad, CA) was added.
The plate was incubated for 30 min at 25 °C. After incubation,
100  μl/well  STOP  solution  (Invitrogen)  was  added.  The
absorbance of the wells was measured at 450 nm using a
Wallac plate reader (PerkinElmer, Waltham, MA).
RESULTS AND DISCUSSION
Figure 1 shows a typical RP-HPLC chromatogram of the
keratin 10 peptide synthesized in this study. The purity of the
peptides was confirmed by RP-HPLC and mass analysis.
Our previous chemical analysis clearly showed that Asp
151 in the T18 peptide and Asp 58 in the T6 peptide of αA-
crystallin [3] and Asp 4 in the T1 peptide of βB2-crystallin
[5] were highly inverted in the lens of elderly donors. In the
previous study, we prepared a highly specific antibody against
the peptide 3R (GLD(Dβ)ATGLD(Dβ)ATGLD(Dβ)AT) that
corresponds to three repeats of a part of the T18 peptide of
αA-crystallin. The antibody recognizes the Dβ-Asp residues
but not the other Asp isomers such as Lα, Lβ and Dα residues
in the T18 peptide of αA-crystallin. The antibody reacted with
aged human αA-crystallin that contains an abundance of Dβ-
Asp residues, while the antibody did not react with young
human  αA-crystallin  that  has  very  low  levels  of  Dβ-Asp
TABLE 1. A LIST OF THE SYNTHETIC PEPTIDES USED FOR THE EXPERIMENT.
Group Sequence Peptide name Remarks column
Leu-Asp-Ala IQTGLD(Lα)ATHAER αA-crystallin T18 Lα →Figure 2
                                                        IQTGLD(Lβ)ATHAER            αA-crystallin T18 Lβ
                                                        IQTGLD(Dα)ATHAER       αA-crystallin T18 Dα
                                                        IQTGLD(Dβ)ATHAER   αA-crystallin T18 Dβ
                                                       TVLD(Lα)AGISEVR             αA-crystallin T6 SA Lα                               →Figure 4
                                                       TVLD(Lβ)AGISEVR             αA-crystallin T6 SA Lβ
                                                       TVLD(Dα)AGISEVR             αA-crystallin T6 SA Dα
                                                       TVLD(Dβ)AGISEVR             αA-crystallin T6 SA Dβ
Leu-Asp-Y TVLD(Lα)SGISEVR αA-crystallin T6 Lα →Figure 3
                                                       TVLD(Lβ)SGISEVR      αA-crystallin T6 Lβ
                                                       TVLD(Dα)SGISEVR             αA-crystallin T6 Dα
                                                       TVLD(Dβ)SGISEVR αA-crystallin T6 Dβ
                                                       TVLD(Lα)RGISEVR         αA-crystallin T6 SR Lα                                →Figure 5
                                                       TVLD(Lβ)RGISEVR             αA-crystallin T6 SR Lβ
                                                       TVLD(Dα)RGISEVR             αA-crystallin T6 SR Dα
                                                       TVLD(Dβ)RGISEVR             αA-crystallin T6 SR Dβ
X-Asp-Y MASD(Lα)HQTQAGK βB2-crystallin T1Lα →Figure 6
                                                        MASD(Lβ)HQTQAGK           βB2-crystallin T1Lβ
                                                        MASD(Dα)HQTQAGK            βB2-crystallin T1Dα
                                                        MASD(Dβ)HQTQAGK            βB2-crystallin T1Dβ
X-Asp-Ala IQTGLD(Lα)ATHAER αA-crystallin T18 LR Lα →Figure 7
                                                        IQTGLD(Dβ)ATHAER αA-crystallin T18 LR Dβ
                                                        NRKD(Lα)AEEWFNQK           keratin 10 (mouse) 330–341Lα                           →Figure 8
                                                        NRKD(Dβ)AEEWFNQK            keratin 10 (mouse) 330–341Dβ
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998residues [14]. The results clearly indicate that the anti peptide
3R antibody recognized only Dβ-Asp residues in peptides and
protein. However, it is unclear whether the reactivity of the
antibody changes depending on the amino acid sequences
surrounding the Dβ-Asp residues. Therefore, we synthesized
the T18 and T6 peptides and related peptides, in which we
replaced several amino acids surrounding the Asp residues. In
addition to the above peptides, we also synthesized a peptide
(NRKDAEEWFNQK) from keratin 10 protein of mouse skin.
Furthermore, synthetic peptides containing 4 different Asp
isomers, L-α-Asp-, L-β-Asp-, D-α-Asp or D-β-Asp were also
prepared for all peptides. Using these peptides, we evaluated
the properties of the anti-peptide 3R antibody.
ELISAs were performed to evaluate the specificity of the
antibody  toward  the  configuration  of  Asp  residues  in  the
peptides. Figure 2, Figure 3, Figure 4, Figure 5, Figure 6,
Figure 7, and Figure 8 shows the results of the ELISAs with
the combination of the 100 times dilution for the first antibody
and 10,000 times dilution for the second antibody. As shown
in Figure 2, the ELISAs clearly demonstrate that the anti-
peptide 3R antibody reacts strongly with the T18 peptide
(IQTGLDATHAER), containing a D-β-Asp residue while the
antibody scarcely reacted with T18 peptides containing the
other  isomers  such  as  L-β-Asp,  D-α-Asp,  L-α-Asp.  The
reactivity  of  the  isomeric  peptides  can  be  expressed  as  a
percentage using the reactivity of T18 Dβ as 100%. Figure 2
clearly indicates that the anti-peptide 3R antibody is specific
for the D-β-Asp residue of the T18 peptide. The result is
completely consistent with that of our previous study [14]. In
contrast,  the  D-β-Asp  residue  in  the  T6  peptide
(TVLDSGISEVR)  was  not  recognized  at  all  by  the  anti-
peptide  3R  antibody.  The  reactivities  of  all  isomeric  T6
peptides were less than 10% that toward the D-β-Asp residue
of the T18 peptide (Figure 3). Therefore, we synthesized T6
SA peptides (TVLDAGISEVR), in which the Ser residue after
the Asp residue was replaced with Ala, and in which the 4
different Asp isomers were included. We then examined the
reactivities of the peptides using the anti-peptide 3R antibody.
The  results  clearly  indicate  that  the  antibody  strongly
recognizes  the  D-β-Asp  residue  of  the  T6SA  peptide
(TVLDAGISEVR)  at  a  level  100%  that  of  the  reactivity
toward the D-β-Asp residue of the T18 peptide, while the
antibody barely reacts with the T6SA peptides (less than 10%)
containing the L-β-Asp, D-α-Asp, L-α-Asp isomers (Figure
4).  This  result  suggests  that  the  anti-peptide  3R  antibody
recognizes the configuration of the D-β-Asp isomer in the T18
Figure 1. The purity of the synthesized
peptides. A: A typical RP-HPLC elution
profile of the purified keratin10 (330–
341) peptide. B: Mass analysis of the
purified  keratin10  (330–341)  peptide.
The  observed  mass  of  the  keratin10
(330–341) peptide is consistent with the
theoretical  mass.  The  purity  of  the
peptide was confirmed to be more than
99%.  The  purities  of  all  synthesized
peptides  were  confirmed  by  a
combination  of  RP-HPLC  and  mass
analysis.
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999and  T6SA  peptides.  Both  T18  and  T6  SA  peptides  have
common  sequence,  namely  Leu-Asp-Ala,  and  the  result
suggests that the antibody recognizes the LD(Dβ)A sequence
of the antigen. As shown in Figure 5, the anti-peptide 3R
antibody also did not react with the D-β-Asp isomer in the
T6SR peptide (TVLDRGISEVR), in which the Ser is replaced
by  Arg.  Figure  6  shows  the  reactivity  of  anti-peptide  3R
antibody  toward  the  T1  peptide  of  βB2-cystallin
(MASD4HQTQAGK). The antibody did not recognize the D-
β-Asp residue in the T1 peptide of human βB2-crystallin. This
result is unsurprising because the T1 peptide of βB2-cystallin
does not contain Leu or Ala in the neighborhood of the D-β-
Asp residue.
Figure 7 shows the reactivity between anti-peptide 3R
antibody  and  the  isomers  of  T18LR  of  αΑ-cystallin
(IQTGRDATHAER).  The  antibody  distinguishes  between
the D-β-Asp residue and the L-α-Asp in the peptide. However,
the intensity is weak compared with reactivity toward the D-
β-Asp residue in T18 or T6 SA peptides. Furthermore, we
examined  whether  the  antibody  recognizes  the  D-β-Asp
residue in a peptide from keratin 10 (mouse) representing
amino acids 330–341 (NRKDAEEWFNQK; Figure 8). The
reactivity toward the D-β-Asp residue of this peptide was 20%
that of T18 peptide. We are able to summarize the above
results as follows: the antibody recognizes D-β-Asp-Ala and
in  addition,  the  antibody  has  strong  affinity  for  peptides
containing Leu-D-β-Asp-Ala. However, the antibody cannot
recognize D-β-Asp-Y when Y is not Ala.
The existence of proteins containing a D-β-Asp residue
in the sequence Asp-Ala, such as Asp151-Ala in human αA-
Figure 2. The reactivity of the peptide
3R  antibody  toward  T18  peptide
isomers.  Results  of  ELISA  assay  for
determining the specificity of the anti-
peptide 3R antibody using 4 different
αA-cystallin  T18  isomeric  peptides
(IQTGLDATHAER) containing 4 Asp
isomers, L-α-Asp-, L-β-Asp-, D-α-Asp
and L-β-Asp. ELISAs were performed
with  a  combination  of  a  100  times
dilution  for  the  first  antibody  and  a
10,000  times  dilution  for  the  second
antibody. The reactivity of the isomeric
peptides  can  be  expressed  as  a
percentage using the reactivity toward
T18 Dβ as 100%. (n=3, ±2σ [sigma]).
Figure 3. The reactivity of the peptide
3R antibody toward T6 peptide isomers.
Results of ELISA assay for determining
the  specificity  of  the  anti-peptide  3R
antibody using 4 different αA-cystallin
T6  isomeric  peptides
(TVLDSGISEVR),  containing  4  Asp
isomers, L-α-Asp-, L-β-Asp-, D-α-Asp
and L-β-Asp. ELISAs were performed
with  a  combination  of  a  100  times
dilution  for  the  first  antibody  and  a
10,000  times  dilution  for  the  second
antibody. The reactivity of the peptides
can be expressed as a percentage using
the reactivity toward T18 Dβ as 100%.
(n=3, ±2σ [sigma]).
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1000crystallin  and  Asp1-Ala  in  β−amyloid  protein  is  widely
known. The Asp in these sites is regularly found to be inverted
from L- to D-Asp under physiologic conditions. Therefore this
antibody  that  recognizes  D-β-Asp-Ala  is  very  useful  for
detection of D-β-Asp containing protein in the living tissue.
The inversion of Asp occurs via a succinimide intermediate
as follows: (i) When the carbonyl group of the side chain of
the L-α-Asp residue is attacked by the nitrogen of the amino
acid  residue  following  the  Asp  residue,  L-succinimide  is
formed by intramolecular cyclization; (ii) L-succinimide may
be converted to D-succinimide through an intermediate that
has the prochiral α-carbon in the plane of the ring; (iii) The
D- and L-succinimide are hydrolyzed at either side of their
two carbonyl groups, yielding both β- and α-Asp residues,
respectively. Thus, four isomers, L-α-Asp, L-β-Asp, D-α-Asp
and D-β-Asp, are simultaneously formed in the protein. The
rate of succinimide formation is expected to depend on the
residue neighboring the Asp. When the neighboring amino
acid of the Asp residue has a small side chain, as with glycine,
alanine or serine, formation of the succinimide intermediate
occurs easily because there is no steric hindrance. Moreover,
when L-α-Asp inverts to D-Asp, about 70% of D-Asp is the
β form, and thus the D-β-Asp isomer predominates over the
other  isomers.  In  fact,  using  this  antibody,  D-β-Asp-
containing peptide/proteins were observed in nonpigmented
ciliary epithelial cells, in drusen, and in the sclera [15] of eye
and in sun-damaged skin of elderly donors [11]. However, the
detection of D-β-Asp containing protein using this antibody
Figure 4. The reactivity of the peptide
3R  antibody  toward  T6  SA  peptide
isomers.  Results  of  ELISA  assay  for
determining the specificity of the anti-
peptide 3R antibody using αA-crystallin
T6 SA peptides (TVLDAGISEVR), in
which the Ser residue following the Asp
residue  was  replaced  by  Ala,  and  in
which the 4 different Asp isomers (L-α-
Asp-, L-β-Asp-, D-α-Asp and L-β-Asp)
were included. ELISAs were performed
with  a  combination  of  a  100  times
dilution  for  the  first  antibody  and  a
10,000  times  dilution  for  the  second
antibody. The reactivity of the peptides
can be expressed as a percentage using
the reactivity toward T18 Dβ as 100%.
(n=3, ±2σ [sigma]).
Figure 5. The reactivity of the peptide
3R  antibody  toward  T6  SR  peptide
isomers.  Results  of  ELISA  assay  for
determining the specificity of the anti-
peptide  3R  antibody  using  T6
SR(TVLDRGISEVR), in which the Ser
residue following the Asp residue was
replaced with Arg, and in which the 4
different Asp isomers (L-α-Asp-, L-β-
Asp-,  D-α-Asp  and  L-β-Asp)  were
included. ELISAs were performed with
a combination of a 100 times dilution for
the first antibody and a 10,000 times
dilution for the second antibody. The
reactivity  of  the  peptides  can  be
expressed  as  a  percentage  using  the
reactivity  toward  T18  Dβ  as  100%.
(n=3, ±2σ [sigma]).
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1001is limited by the sequence surrounding the Asp residues. For
example, although Asp 58 of αA-crystallin and Asp 4 of βB2-
crystallin in the lens of elderly donors showed high D/L ratios,
the anti-peptide 3R antibody does not react with these Asp
residues because of the lack of an Asp-Ala sequence. These
results indicate that experiments using only this antibody are
insufficient for a thorough identification of D-Asp containing
proteins. Instead, chemical analysis, including the purification
of protein, the analysis of optical isomers of amino acids with
HPLC  is  required.  However,  chemical  analysis  is  very
complicated and it takes a long time to obtain the D/L ratio of
Asp in the protein. Therefore, as a first step in the detection
of  D-β-Asp-containing  peptide/proteins  in  living  tissues,
immunohistochemical staining and western blotting using this
antibody  are  useful.  However,  chemical  analysis  is  still
required  after  such  a  screening.  The  advantage  of
immunohistochemistry using this antibody is that it can show
the  localization  of  D-β-Asp-containing  peptide/proteins  in
living tissues. However, to detect more D-β-Asp containing
proteins, we need to synthesize the other 3R peptides, with
different sequences for use as antigen. If antibodies against
peptides containing 20 variations of Leu-D-β-Asp-X, (X is
any amino acids) could be prepared, all D-β-Asp containing
proteins could potentially be detected in living tissues.
Together with the chemical analysis, the anti-peptide 3R
antibody is a powerful tool for the study of the mechanism of
D-β-Asp formation and the study of aging of proteins and age-
related diseases.
Figure 6. The reactivity of the peptide
3R  antibody  toward  bB2  T1  peptide
isomers.  Results  of  ELISA  assay  for
determining the specificity of the anti-
peptide 3R antibody using βB2-cystllin
T1  peptide  (MASD4HQTQAGK)
isomers, in which the 4 different Asp
isomers (L-α-Asp-, L-β-Asp-, D-α-Asp
and L-β-Asp) were included. ELISAs
were performed with the combination of
a 100 times dilution for the first antibody
and  a  10,000  times  dilution  for  the
second antibody. The reactivity of the
peptides  can  be  expressed  as  a
percentage using the reactivity toward
T18 Dβ as 100%. (n=3, ±2σ [sigma]).
Figure 7. The reactivity of the peptide
3R  antibody  toward  T18  LR  peptide
isomers.  Results  of  ELISA  assay  for
determining the specificity of the anti-
peptide  3R  antibody  using  T18LR  of
αΑ-cystallin  (IQTGRDATHAER)  in
which the Leu residue before the Asp
residue was replaced with Arg, and in
which the 2 different Asp isomers (L-α-
Asp-  and  L-β-Asp)  were  included.
ELISAs  were  performed  with  a
combination of a 100 times dilution for
the first antibody and a 10,000 times
dilution for the second antibody. The
reactivity  of  the  peptides  can  be
expressed  as  a  percentage  using  the
reactivity  toward  T18  Dβ  as  100%.
(n=3, ±2σ [sigma]).
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